PMC:7306567 / 30433-30552 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"282","span":{"begin":61,"end":79},"obj":"Disease"}],"attributes":[{"id":"A282","pred":"tao:has_database_id","subj":"282","obj":"MESH:D045169"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T147","span":{"begin":61,"end":65},"obj":"Disease"}],"attributes":[{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T212","span":{"begin":21,"end":35},"obj":"Chemical"},{"id":"T213","span":{"begin":44,"end":47},"obj":"Chemical"},{"id":"T215","span":{"begin":99,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A212","pred":"chebi_id","subj":"T212","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A213","pred":"chebi_id","subj":"T213","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A214","pred":"chebi_id","subj":"T213","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"},{"id":"A215","pred":"chebi_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T41","span":{"begin":44,"end":47},"obj":"Phenotype"}],"attributes":[{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T221","span":{"begin":0,"end":119},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T289","span":{"begin":21,"end":35},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T290","span":{"begin":61,"end":65},"obj":"SP_10"},{"id":"T291","span":{"begin":99,"end":114},"obj":"CHEBI:50858;CHEBI:50858"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}

{"project":"2_test","denotations":[{"id":"32572532-22895826-47963457","span":{"begin":41,"end":42},"obj":"22895826"},{"id":"32572532-12890854-47963458","span":{"begin":116,"end":118},"obj":"12890854"},{"id":"T58330","span":{"begin":41,"end":42},"obj":"22895826"},{"id":"T34258","span":{"begin":116,"end":118},"obj":"12890854"}],"text":"IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]"}